The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
Open accessAbstract
BACKGROUND: Approximately 50% of patients with heart failure have a left ventricular ejection fraction of at least 45%, but no therapies have been shown to improve the outcome of these patients. Therefore, we studied the effects of irbesartan in patients with this syndrome. METHODS: We enrolled 4128 patients who were at least 60 years of age and had New York Heart Association class II, III, or IV heart failure and an ejection fraction of at least 45% and randomly assigned them to receive 300 mg of irbesartan or placebo per day. The primary composite outcome was death from any cause or hospitalization for a cardiovascular cause (heart failure, myocardial infarction, unstable angina, arrhythmia, or stroke). Secondary outcomes included death from heart failure or hospitalization for heart failure, death from any cause and from cardiovascular causes, and quality of life. RESULTS: During a mean follow-up of 49.5 months, the primary outcome occurred in 742 patients in the irbesartan group and 763 in the placebo group. Primary event rates in the irbesartan and placebo groups were 100.4 and 105.4 per 1000 patient-years, respectively (hazard ratio, 0.95; 95% confidence interval [CI], 0.86 to 1.05; P=0.35). Overall rates of death were 52.6 and 52.3 per 1000 patient-years, respectively (hazard ratio, 1.00; 95% CI, 0.88 to 1.14; P=0.98). Rates of hospitalization for cardiovascular causes that contributed to the primary outcome were 70.6 and 74.3 per 1000 patient-years, respectively (hazard ratio, 0.95; 95% CI, 0.85 to 1.08; P=0.44). There were no significant differences in the other prespecified outcomes. CONCLUSIONS: Irbesartan did not improve the outcomes of patients with heart failure and a preserved left ventricular ejection fraction. (ClinicalTrials.gov number, NCT00095238.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“once weekly subcutaneous injection with semaglutide resulted in a marked and sustained weight loss of >15% in patients who are overweight or obese.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Self-citationThe Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Pfeffer, M. A., Swedberg, K. B., Granger, C. B., Held, P., McMurray, J. J. V., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,895
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,001
Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
Lund, L. H., Oldgren, J., & James, S. K. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0325-0 · Cited by 91
The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials
Oghina, S., Bougouin, W., Bézard, M., Kharoubi, M., Michel Komajda, N., Solal, A. C., Mebazaa, A., Damy, T., & Bodez, D. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2020.12.005 · Cited by 92
Kristensen, S. L., Køber, L., Jhund, P. S., Solomon, S. D., KJEKSHUS, J. K., McKelvie, R. S., Zile, M. R., Granger, C. B., Wikstrand, J., Michel Komajda, N., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.012284 · Cited by 88
Self-citationExercise intolerance in heart failure with preserved ejection fraction: more than a heart problem.
Upadhya, B., Haykowsky, M. J., Eggebeen, J., & Kitzman, D. W. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.03.013 · Cited by 98
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Kjeldsen, S. E., von Lueder, T. G., Smiseth, O. A., Wachtell, K., Mistry, N., Westheim, A. S., Hopper, I., Julius, S., Pitt, B., Reid, C. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.14057 · Cited by 91
Ma, C., Luo, H., Fan, L., Liu, X., & Gao, C. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209646 · Cited by 95
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
Lekavich, C. L., Barksdale, D. J., Neelon, V. J., & Wu, J. R. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9506-7 · Cited by 93
Lip, G. Y. H., Ponikowski, P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L. H., Marín, F. R., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs073 · Cited by 89
Self-citationTiller, D., Ruß, M., Greiser, K. H., Nuding, S., Ebelt, H., Kluttig, A., Kors, J. A., Thiery, J., Bruegel, M., Haerting, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059225 · Cited by 90
Vaduganathan, M., Michel, A., Hall, K., Mulligan, C., Nodari, S., Shah, S. J., Senni, M., Triggiani, M., Butler, J., & Gheorghiade, M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.442 · Cited by 86
Selvaraj, S., Claggett, B. L., Böhm, M., Anker, S. D., Vaduganathan, M., Zannad, F. M., Pieske, B. M., Lam, C. S. P., Anand, I. S., Shi, V. C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.009 · Cited by 90
Self-citationRoh, J. D., Houstis, N. E., Yu, A., Chang, B. J., Yeri, A., Li, H., Hobson, R., Lerchenmüller, C., Vujić, A., Chaudhari, V., et al. (2020) · Aging Cell · doi:10.1111/acel.13159 · Cited by 95
Mancia, G., Kjeldsen, S. E., Kreutz, R. H., Pathak, A., Grassi, G. M., & Esler, M. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19020 · Cited by 92
Jhund, P. S., Claggett, B. L., Packer, M., Zile, M. R., Voors, A. A., Pieske, B. M., Lefkowitz, M. P., Shi, V. C., Bransford, T. L., McMurray, J. J. V., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.76 · Cited by 83
Self-citationPagel, P. S., Tawil, J. N., Boettcher, B. T., Izquierdo, D. A., Lazicki, T. J., Crystal, G. J., & Freed, J. K. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.016 · Cited by 86
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials
Verdecchia, P., Gentile, G., Angeli, F., Mazzotta, G., Mancia, G., & Reboldi, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328338e2bb · Cited by 87
Damman, K., Moreno, A. C. P., Anand, I. S., Michel Komajda, N., McKelvie, R. S., Zile, M. R., Massie, B. M., Carson, P. E., & McMurray, J. J. V. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.087 · Cited by 83
Self-citationThe two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction
Abraham, D., Lee, T. E., Watson, L. J., Mao, L., Chandok, G., Wang, H., Frangakis, S. G., Pitt, G. S., Shah, S. H., Wolf, M. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95945 · Cited by 83
Filbey, L., Zhu, J. W., D’Angelo, F., Thabane, L., Khan, M. S., Lewis, E. F., Patel, M. R., Powell‐Wiley, T. M., Miranda, J. J., Zuhlke, L. J., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac810 · Cited by 82
Treatment for chronic heart failure in the elderly: current practice and problems
Abete, P., Testa, G., Della‐Morte, D., Gargiulo, G., Galizia, G., de Santis, D., Magliocca, A., Basile, C., & Cacciatore, F. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9363-6 · Cited by 82
McMurray, J. J. V. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr093 · Cited by 82
Self-citationGupta, J., Dominic, E. A., Fink, J. C., OJO, A. O., Barrows, I. R., Reilly, M. P., Townsend, R. R., Joffe, M. M., Rosas, S. E., Wolman, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124772 · Cited by 82
Pandey, A., Khan, H., Newman, A. B., Lakatta, E. G., Forman, D. E., Butler, J., & Berry, J. D. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08327 · Cited by 80
Kasiakogias, A., Rosei, E. A., Camafort, M., Ehret, G., Faconti, L., Ferreira, J. P., Brguljan-Hitij, J., Januszewicz, A., Kahan, T., Manolis, A. J., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002910 · Cited by 81
Effects of blood pressure lowering treatment in hypertension
Thomopoulos, C., Parati, G., & Zanchetti, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000972 · Cited by 79
Heart failure with preserved ejection fraction: current management and future strategies
Tschöpe, C., Birner, C. M., Böhm, M., Bruder, O., Frantz, S., Luchner, A., Maier, L. S., Störk, S., Kherad, B., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1170-6 · Cited by 80
Medical therapy for chronic heart failure
Krum, H., & Teerlink, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61038-6 · Cited by 82
How to Manage Heart Failure With Preserved Ejection Fraction
Desai, A. S., Lam, C. S. P., McMurray, J. J. V., & Redfield, M. M. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.03.011 · Cited by 83
Self-citationZile, M. R., Bourge, R. C., Redfield, M. M., Zhou, D., Baicu, C. F., & Little, W. C. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2013.12.002 · Cited by 78
Self-citationRector, T. S., Carson, P. E., Anand, I. S., McMurray, J. J. V., Zile, M. R., McKelvie, R. S., Michel Komajda, N., Kuskowski, M. A., Massie, B. M., & for the I-PRESERVE Trial Investigators (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.964221 · Cited by 78
Self-citationMurine Models of Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
Horgan, S. J., Watson, C., Glezeva, N., & Baugh, J. A. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.09.001 · Cited by 77
Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management
Meagher, P., Adam, M., Civitarese, R., Bugyei‐Twum, A., & Connelly, K. A. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.02.026 · Cited by 79
Taguchi, I., Toyoda, S., Takano, K., Arikawa, T., Kikuchi, M., Ogawa, M., Abe, S., Node, K., & Inoue, T. (2013) · Hypertension Research · doi:10.1038/hr.2013.3 · Cited by 78
Stramba‐Badiale, M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq094 · Cited by 77
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 76
Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
TERAMOTO, K., Teng, T. K., Chandramouli, C., Tromp, J., Sakata, Y., & Lam, C. S. P. (2022) · Cardiac failure review · doi:10.15420/cfr.2022.06 · Cited by 76
O’Connell, T. D., Block, R., Huang, S., & Shearer, G. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.003 · Cited by 76
Damman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., & McMurray, J. J. V. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.609 · Cited by 75
Self-citationEdelmann, F., Schmidt, A. G., Gelbrich, G., Binder, L., Herrmann‐Lingen, C., Halle, M., Hasenfuss, G. P., Wachter, R., & Pieske, B. M. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq087 · Cited by 74
Ventricular Remodeling in Heart Failure with Preserved Ejection Fraction
Shah, A. M. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0166-4 · Cited by 74
Heart failure with preserved ejection fraction based on aging and comorbidities
Lin, Y. H., Fu, S., Yao, Y., Li, Y., Zhao, Y., & Luo, L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02935-x · Cited by 81
Renal-Cardiac Crosstalk in the Pathogenesis and Progression of Heart Failure
Noels, H., van der Vorst, E. P. C., Rubin, S., Emmett, A., Marx, N., Tomaszewski, M., & Jankowski, J. (2025) · Circulation Research · doi:10.1161/circresaha.124.325488 · Cited by 92
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 91
Sipahi, İ., Swaminathan, A. C., Natesan, V., Debanne, S. M., Simon, D. I., & Fang, J. C.-T. (2011) · Stroke · doi:10.1161/strokeaha.111.636829 · Cited by 77
Maeder, M. T., Rickenbacher, P. R., Rickli, H., Abbühl, H., Gutmann, M., Erné, P., Vuilliomenet, A., Peter, M., Pfisterer, M. E., Rocca, H. B., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft076 · Cited by 75
Pandey, A., Garg, S. K., Matulevicius, S. A., Shah, A. M., Garg, J., Drazner, M. H., Amin, A., Berry, J. D., Marwick, T. H., Marso, S. P., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002137 · Cited by 75
Heart Failure with Preserved Ejection Fraction
Gladden, J. D., Chaanine, A. H., & Redfield, M. M. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-090654 · Cited by 76
Association of Cardiac Troponin T With Left Ventricular Structure and Function in CKD
Mishra, R., Li, Y., deFilippi, C. R., Fischer, M. J., Yang, W. P., Keane, M. G., Chen, J., He, J., Kallem, R. R., Horwitz, E. J., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.034 · Cited by 75
Age Disparities in Heart Failure Research
Kitzman, D. W., & Rich, M. W. (2010) · JAMA · doi:10.1001/jama.2010.1592 · Cited by 74
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74
Farmakis, D. T., Simitsis, P., Bistola, V., Triposkiadis, F. K., Ikonomidis, I., Katsanos, S., Bakosis, G., Hatziagelaki, E. E., Lekakis, J. P., Mebazaa, A., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1063-0 · Cited by 73
Docherty, K. F., Henderson, A. D., Jhund, P. S., Claggett, B. L., Desai, A. S., Mueller, K., Viswanathan, P., Scalise, A. V., Lam, C. S. P., Senni, M., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.072011 · Cited by 79
Self-citationGeographic Differences in Heart Failure Trials
Ferreira, J. P., Girerd, N., Rossignol, P., & Zannad, F. M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.326 · Cited by 74
Kato, S., Saito, N., Kirigaya, H., Gyotoku, D., Iinuma, N., Kusakawa, Y., Iguchi, K., Nakachi, T., Fukui, K., Futaki, M., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.048 · Cited by 72
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 73
A review of heart failure management in the elderly population
Cheng, J. W. M., & Nayar, M. (2009) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2009.10.001 · Cited by 73
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm
Ponikowski, P. P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L., Marín, F. R., Lane, D. A., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0578 · Cited by 73
Self-citationWu, C., Su, M.-Y. M., Lee, J.-K., Chiang, F., Hwang, J., Lin, J.-L., Chen, J.-J., Liu, F., & Tsai, C. (2015) · Scientific Reports · doi:10.1038/srep17007 · Cited by 73
Integrating the Myocardial Matrix Into Heart Failure Recognition and Management
Spinale, F. G., & Zile, M. R. (2013) · Circulation Research · doi:10.1161/circresaha.113.300309 · Cited by 70
Self-citationZile, M. R., & Baicu, C. F. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9472-1 · Cited by 71
Self-citationTinetti, M. E., McAvay, G., Trentalange, M., Cohen, A. B., & Allore, H. G. (2015) · BMJ · doi:10.1136/bmj.h4984 · Cited by 58
Sudden Cardiac Death in Heart Failure Patients With Preserved Ejection Fraction
Adabağ, S., Smith, L. G., Anand, I. S., Berger, A. K., & Luepker, R. V. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.08.357 · Cited by 71
Sakata, Y., Miyata, S., Nochioka, K., Miura, M., Takada, T., Tadaki, S., Takahashi, J. A., & Shimokawa, H. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1009 · Cited by 69
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
Cheng, R. K.-H., Vasbinder, A. L., Levy, W. C., Goyal, P., Griffin, J. M., Leedy, D. J., & Maurer, M. S. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022859 · Cited by 71
Heart failure etiology impacts survival of patients with heart failure
Pecini, R., Møller, D. V., Torp-Pedersen, C. T., Hassager, C., & Køber, L. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.01.011 · Cited by 70
New roles for renin and prorenin in heart failure and cardiorenal crosstalk
Schroten, N. F., Gaillard, S., van Veldhuisen, D. J., Szymanski, M. K., Hillege, H. L., & de Boer, R. A. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9262-2 · Cited by 70
Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
Zeng, H., & Chen, J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00015 · Cited by 70
Shen, L., Rørth, R., Cosmi, D., Kristensen, S. L., Petrie, M. C., Cosmi, F., Latini, R., Køber, L., Anand, I. S., Carson, P. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1535 · Cited by 69
Self-citationEjiri, K., Miyoshi, T., Kihara, H., Hata, Y., Nagano, T., Takaishi, A., Toda, H., Nanba, S., Nakamura, Y., Akagi, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015103 · Cited by 73
Solomon, S. D., Ostrominski, J. W., Vaduganathan, M., Claggett, B. L., Jhund, P. S., Desai, A. S., Lam, C. S. P., Pitt, B., Senni, M., Shah, S. J., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3266 · Cited by 76
Self-citationToma, M., Ezekowitz, J. A., Bakal, J. A., O’Connor, C. M., Hernandez, A. F., Sardar, M. R., Zolty, R., Massie, B. M., Swedberg, K. B., Armstrong, P. W., et al. (2013) · European Journal of Heart Failure · doi:10.1002/ejhf.19 · Cited by 69
Self-citationvan Empel, V. P. M., Mariani, J. A., Borlaug, B. A., & Kaye, D. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001293 · Cited by 69
Khan, M. S., Fonarow, G. C., Khan, H., Greene, S. J., Anker, S. D., Gheorghiade, M., & Butler, J. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12204 · Cited by 69
Enfermedad cardiovascular en el anciano
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.05.001 · Cited by 72
Heart Failure with Preserved Ejection Fraction in Older Adults
Upadhya, B., & Kitzman, D. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.005 · Cited by 69
Schelbert, E. B., Sabbah, H. N., Butler, J., & Gheorghiade, M. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005619 · Cited by 69
Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
Eklind-Cervenka, M. (2011) · JAMA · doi:10.1001/jama.2010.1949 · Cited by 68
Buono, M. G. D., Iannaccone, G., Scacciavillani, R., Carbone, S., Camilli, M., Niccoli, G., Borlaug, B. A., Lavie, C. J., Arena, R. A., Crea, F., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.011 · Cited by 70
Zhang, N., Ma, Q., You, Y., Xia, X., Xie, C., Huang, Y., Wang, Z., Ye, F., Yu, Z., & Xie, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65802 · Cited by 71
Sakata, Y., Shiba, N., TAKAHASHI, J. C., Miyata, S., Nochioka, K., Miura, M., Takada, T., Saga, C., Shinozaki, T., Sugi, M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu504 · Cited by 67
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology
Maurer, M. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.039 · Cited by 66
Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure
Mori, J., Zhang, L., Oudit, G. Y., & Lopaschuk, G. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.010 · Cited by 65
The causes, consequences, and treatment of left or right heart failure
Peteiro, J., Peteiro-Vázquez, J., Gacía-Campos, A., García‐Bueno, L., Abugattás-de-Torres, J. P., & Castro‐Beiras, A. (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s10669 · Cited by 76
Cardiovascular Disease in Women
Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65
Jhund, P. S., Anand, I. S., Michel Komajda, N., Claggett, B. L., McKelvie, R. S., Zile, M. R., Carson, P. E., & McMurray, J. J. V. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.274 · Cited by 65
Self-citationNatriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Vaduganathan, M., Claggett, B. L., Packer, M., McMurray, J. J. V., Rouleau, J. L., Zile, M. R., Swedberg, K. B., & Solomon, S. D. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.02.007 · Cited by 65
Self-citationAlagiakrishnan, K., Banach, M., Jones, L. G., Datta, S., Ahmed, A., & Aronow, W. S. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.660493 · Cited by 65
Packer, M. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.09.002 · Cited by 65
Zaragoza‐Macias, E., Zaidi, A. N., Dendukuri, N., & Marelli, A. J. (2018) · Circulation · doi:10.1161/cir.0000000000000604 · Cited by 65
Michalska, M., Bielecka-Dabrowa, A. M., von Haehling, S., Anker, S. D., Rysz, J., & Banach, M. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.76279 · Cited by 68
Omori, Y., Ohtani, T., Sakata, Y., Mano, T., Takeda, Y., Tamaki, S., Tsukamoto, Y., Kamimura, D., Aizawa, Y., 剛, 三., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283569c5a · Cited by 64
Mishra, R., Li, Y., Ricardo, A. C., Yang, W. P., Keane, M. G., Cuevas, M., Christenson, R. H., deFilippi, C. R., Chen, J., He, J., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.10.019 · Cited by 64
Similarities and Differences Between HFmrEF and HFpEF
Li, P., Zhao, H., Zhang, J., Ning, Y., Tu, Y., Xu, D., & Zeng, Q. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.678614 · Cited by 66
Skeletal muscle alterations in HFrEF vs. HFpEF
Adams, V., Linke, A. H.-P., & Winzer, E. B. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0361-9 · Cited by 66
Wolsk, E., Claggett, B. L., Køber, L., Pocock, S., Yusuf, S., Swedberg, K. B., McMurray, J. J. V., Granger, C. B., Pfeffer, M. A., & Solomon, S. D. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1073 · Cited by 63
Self-citationEstrogen and calcium handling proteins: new discoveries and mechanisms in cardiovascular diseases
Jiao, L., Machuki, J. O., Wu, Q., Shi, M., Fu, L., Adekunle, A. O., Tao, X., Xu, C., Hu, X., Yin, Z., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00734.2019 · Cited by 64
Lewis, G. A., Schelbert, E. B., Naish, J. H., Bedson, E., Dodd, S. R., Eccleson, H., Clayton, D., Duran-Jimenez, B., McDonagh, T. A., Williams, S. G., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06876-y · Cited by 62
Heart Failure with Preserved Ejection Fraction—a Concise Review
Adamczak, D., Oduah, M.-T. A., Kiebalo, T., Nartowicz, S., Bęben, M., Pochylski, M., Ciepłucha, A., Gwizdała, A., Lesiak, M., & Straburzyńska‐Migaj, E. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01349-3 · Cited by 65
Martin, N., Manoharan, K., Davies, C., & Lumbers, R. T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012721.pub3 · Cited by 67
Detection and Management of Geographic Disparities in the TOPCAT Trial
Bristow, M. R., Enciso, J. S., Gersh, B. J., Grady, C., Rice, M. M., Singh, S. N., Sopko, G. S., Boineau, R., Rosenberg, Y., & Greenberg, B. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.001 · Cited by 64
Metadata
- Authors
- Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., & Ptaszynska, A.
- Affiliations
- San Francisco VA Medical Center (US)
- Georgetown University (US)
- University of Glasgow (GB)
- Hamilton Health Sciences (CA)
- Medical University of South Carolina (US)
- University of Wisconsin–Madison (US)
- Bristol-Myers Squibb (United States) (US)
- Sanofi (United States) (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-12-04
- Volume
- 359
- Issue
- 23
- Pages
- 2456-2467
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068519950
- Cited by
- 1,960
- References
- 37
- Citations by year
- 2026: 61 · 2025: 72 · 2024: 92 · 2023: 94 · 2022: 128 · 2021: 120 · 2020: 123 · 2019: 118 · 2018: 117 · 2017: 138 · 2016: 105 · 2015: 127 · 2014: 119 · 2013: 122 · 2012: 109
- FWCI
- 75.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Use Siena air (University of Siena) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- irbesartan, heart failure with preserved ejection fraction, angiotensin receptor blockers, cardiovascular mortality, cardiovascular hospitalization, heart failure hospitalization, quality of life, elderly patients
- MeSH terms
- Irbesartan, Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Biphenyl Compounds, Cardiovascular Diseases, Drug Therapy, Combination, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Quality of Life, Stroke Volume, Tetrazoles, Proportional Hazards Models, Treatment Failure, Angiotensin II Type 1 Receptor Blockers, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
